FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

700402009: Pitavastatin calcium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2990462015 Pitavastatin calcium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2990466017 Pitavastatin calcium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
834191000172115 pitavastatine calcique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pitavastatin calcium Is a Pitavastatin (substance) false Inferred relationship Some
Pitavastatin calcium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. HMG-CoA reductase inhibitor true Inferred relationship Some
Pitavastatin calcium Is a Enzyme inhibitor false Inferred relationship Some
Pitavastatin calcium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Pitavastatin (substance) true Inferred relationship Some
Pitavastatin calcium Is a Quinoline true Inferred relationship Some
Pitavastatin calcium Is a Substance with cyclopropane structure (substance) true Inferred relationship Some
Pitavastatin calcium Is a HMG-CoA reductase inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely pitavastatin (as pitavastatin calcium) 4 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pitavastatin calcium Inferred relationship Some 1
Product containing precisely pitavastatin (as pitavastatin calcium) 2 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pitavastatin calcium Inferred relationship Some 1
Product containing precisely pitavastatin (as pitavastatin calcium) 1 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pitavastatin calcium Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start